StonvexLoading…
StonvexStonvexStonvexCore line items from LNZA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $55.84M | $49.59M | $62.63M | $37.34M |
Operating Income | $-79.16M | $-108.93M | $-106.38M | $-75.60M |
Net Income | $-48.95M | $-137.73M | $-134.10M | $-76.36M |
EPS (Diluted) | $-22.27 | $-69.71 | $-0.79 | $-12.37 |
Total Assets | $100.21M | $174.68M | $241.62M | $176.86M |
Total Liabilities | $90.93M | $161.24M | $127.15M | $124.95M |
Cash & Equivalents | $13.16M | $43.50M | $75.58M | $83.05M |
Free Cash Flow OCF − CapEx | $-66.11M | $-94.37M | $-105.85M | $-95.44M |
Shares Outstanding | 2.32M | 1.95M | 196.64M | 10.42M |